Overview of age-variations
Age group comparisons |
PMID |
Age/Age interval, Gender |
Value (unit of measurement) |
Method |
Sample |
18384253 |
Age 24.5 ± 3, Gender ⚥ |
0.73 (mean value of the compound area) |
LC-MS; GC-MS |
plasma |
18384253 |
Age 40.8 ± 5.6, Gender ⚥ |
1.05 (mean value of the compound area) |
LC-MS; GC-MS |
plasma |
18384253 |
Age 55.6 ± 3.7, Gender ⚥ |
1.23 (mean value of the compound area) |
LC-MS; GC-MS |
plasma |
17474139 |
Age 36.6 ± 5.5, Gender ⚥ |
37.3 (mmol/mol ) |
H-NMR |
urine |
17474139 |
Age 54.5 ± 7.6, Gender ⚥ |
39.5 (mmol/mol ) |
H-NMR |
urine |
23701591 |
Age [34-39], Gender ⚥ (American population) |
2.45 (signal intensity) |
HNMR |
urine |
23701591 |
Age [72-84], Gender ⚥ (American population) |
1.98 (signal intensity) |
HNMR |
urine |
12535825 |
Age 26 ± 5, Gender ♂ |
0.68 (μmol/ml) |
radioimunoassay |
plasma |
12535825 |
Age 67 ± 5, Gender ♂ |
0.92 (μmol/ml) |
radioimunoassay |
plasma |
27374292 |
Age [25–35] (median=32), Gender ♂ (Japanese) |
0.951886 (average level of metabolite) |
UHPLC-MS/MS HILIC |
serum |
27374292 |
Age [55–64 (median=60), Gender ♂ (Japanese) |
1.20589 (average level of metabolite) |
UHPLC-MS/MS HILIC |
serum |
Linear regression |
PMID |
Age/Age interval, Gender |
Value (unit of measurement) |
Method |
Sample |
23838602 |
Age [17–85], Gender ⚥ |
0.008 (β) |
UPLC-MS/MS; GC-MS |
serum, plasma |
log2 ratio/log2(FC) |
PMID |
Age/Age interval, Gender |
Value (unit of measurement) |
Method |
Sample |